Calidi Biotherapeutics Inc.
Biotechnology
Healthcare
CLDI
2.25 M shares
NYSE MKT US
traded
23 Sep 2025
listed
no
open
1.56
52 week high
12.10
high
1.60
52 week low
0.00
low
1.55
growth
46.79 %
previous Close
1.61
P/E ratio
-1
market cap
14.41 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
-1.99 %
-964.64 %
eps surprise
-50.97 %
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top